Talvey Injection
Product Images NDC 57894-469

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Talvey (NDC 57894-469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Biotech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (3 mg Vial Carton)

Principal Display Panel (3 mg Vial Carton)
Packaging label for Talvey (talquetamab-tgvs) injection, 3 mg per 1.5 mL (2 mg/mL) single-dose vial, manufactured by Janssen Biotech, Inc. Label includes dosage form, storage instructions, barcode, lot and expiration date note, and warnings to discard unused portion and use by healthcare providers only.*
FDA Label Image

Principal Display Panel (40 mg Vial Carton)

Principal Display Panel (40 mg Vial Carton)
Packaging label for Talvey (talquetamab-tgvs) injection, 40 mg/mL, a single-dose vial for subcutaneous injection. The label includes the National Drug Code (NDC) 57894-470-01, manufacturer Janssen Biotech, Inc., and storage instructions to refrigerate at 2°C to 8°C. The label also notes no preservatives and advises dispensing a medication guide to patients.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.